Food and Drug Administration late last month updated its warning label for Ozempic, saying that the drug may lead to ileus, a condition in which the intestines dont work correctly
Access and Affordability Challenges: Despite strong clinical benefits, fewer than 1% of eligible US adults are able to afford GLP-1 treatments at current net prices, emphasizing the need for broader coverage and policy solutions
Its not just filling out a form online and then having some random healthcare provider sign off on it, he said
Standard dosing is 3 to 5 grams daily
This period is critical for building tolerance and setting the stage for long-term success
Tirzepatide was FDA-approved to treat type 2 diabetes under the brand name Mounjaro in May 2002, and then it was also granted approval to be used for the treatment of obesity and weight management under the brand name Zepbound in November 2023